CB1r peptide agonists RVD and VD, impair memory processing in mice, but in Amyloid-beta1-42-treated mice, RVD and VD improve Aβ1-42-induced memory impairment (Zhang et al., 2016[83]). The gene discussed is CNR1; the disease is memory impairment.